Skip to main content

Journals in Molecular biology cellular biology and genetics

This collection offers insights into gene expression, cell signalling, and genetic regulation. Supporting researchers, clinicians, and students, it features advanced techniques, genetic engineering, and disease mechanisms, fostering innovations in personalized medicine, regenerative therapies, and molecular diagnostics.

  • Micron

    • ISSN: 0968-4328
    The International Research and Review Journal for MicroscopyMicron is an interdisciplinary forum for all work that involves new applications of microscopy or where advanced microscopy plays a central role. The journal publishes research papers on the design, methods, application, practice or theory of microscopy and microanalysis, including reports on light optical, electron-beam, X-ray microtomography, ion microscopy and scanning-probe imaging.It also carries review papers, short communications, thematic issues on contemporary developments in microscopy & microanalysis, as well as tutorial papers describing microscopy techniques for current practitioners or newcomers in the field. The journal embraces original research in which microscopy has contributed significantly to knowledge in biology, life science, nanoscience and nanotechnology, materials science and engineering.Authors are encouraged to contact one of the Editors directly to discuss Review or Tutorial proposals.
  • Journal of Forensic and Legal Medicine

    • ISSN: 1752-928X
    An International journal of Forensic and Legal MedicineThe Journal of Forensic and Legal Medicine publishes topical articles on aspects of forensic and legal medicine. Specifically, the Journal supports research that explores the medical principles of care and forensic assessment of individuals, whether adult or child, in contact with the judicial system. It is a fully peer-review hybrid journal with a broad international perspective. It is the official journal for the Faculty of Forensic and Legal Medicine of the Royal College of Physicians.The Journal accepts submissions of original research, review articles, and pertinent case studies, editorials, and commentaries in relevant areas of Forensic and Legal Medicine, Context of Practice, and Education and Training. All aspects of the medical principles of care and forensic assessment of individuals in contact with the judicial system are examined and the journal has a broad international perspective.Topics covered in the journal include, but are not necessarily limited to, the following, particularly within the clinical setting:Forensic medicine training, forensic medicine national systemsHealthcare in police and prison custody, death in custody and restraint injuriesDeath investigation and causes of deathSuicide, para-suicide and deliberate self-harmChild abuse and neglectInterpersonal violence, assault and injury, personal injury, elder abuse, domestic violenceSexual assaultHuman rights when involving refugee and asylum medicineTraffic and transportation medicineDrug and alcohol misuse, drink and drug drivingMedical law and medical negligenceMass disasterTortureExtra... deathsHuman rightsThe Journal adheres to strict publication ethical guidelines, and actively supports a culture of inclusive and representative publication.
  • Marine Genomics

    • ISSN: 1874-7787
    The journal Marine Genomics publishes papers on all functional and evolutionary aspects of genes, chromatin, chromosomes and (meta)genomes of marine (and freshwater) organisms. It deals with new genome-enabled insights into the broader framework of environmental science. Topics within the scope of this journal include: Population genomics and ecology Evolutionary and developmental genomics Comparative genomics Metagenomics Environmental genomics Systems biologyMore specific topics include: geographic and phylogenomic characterization of aquatic organisms, metabolic capacities and pathways of organisms and communities, biogeochemical cycles, genomics and integrative approaches applied to microbial ecology including (meta)transcriptomic... and (meta)proteomics, tracking of infectious diseases, environmental stress, global climate change and ecosystem modelling.
  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeutics.Design of novel therapeutic approaches employing cell/EV/gene products.Scientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Scientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validation.Global/re... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherap... does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translat... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology.Fund... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer.
  • Journal of Biomedical Informatics

    • ISSN: 1532-0464
    Endorsed by the American Medical Informatics AssociationThe Journal of Biomedical Informatics (JBI) is the premier methodology journal in the field of biomedical informatics. JBI publishes research on new methodologies and techniques that have general applicability and form the basis for the evolving science of biomedical informatics. Papers should focus on a real-world biomedical or clinical problem, develop a novel approach to address the problem, and evaluate its appropriateness in comparison to the current state-of-the-art (SoA) methods. Involvement of healthcare professionals in motivating the work and evaluation of results is expected.Focus Areas and Topics of InterestJBI seeks to publish papers that make a conceptual contribution to the field, typically by describing an innovation in methodology or technique or by discussing substantive generalizable lessons that have been learned in the context of an informatics project. When a methodological contribution has a theoretical basis, that theory is an appropriate emphasis for papers as well. Research papers may also present a novel "method of methods" explaining how to apply the existing methods to a space of biomedical problems that share unique characteristics influencing the choice of methods.JBI publishes papers on a wide range of informatics topics. However, across these topics, papers must build on deep understanding and utilization of medical domain knowledge and should consider pragmatic translation for clinical care or applications. Topics of interest include (but are not limited to) clinical decision support, patient safety, natural language processing, artificial intelligence and machine learning, knowledge representation for healthcare, translational bioinformatics, clinical research informatics, and clinical informatics. Additional considerations for papers in the areas of translational bioinformatics, machine learning, security and privacy are provided below. Irrespective of the topic, papers must focus on novel informatics methods and its comparison to the current approaches.Manuscrip... can be submitted in the following categories: original research, methodological review, commentaries, special communication, letters to the editor, book reviews, and editorials (see additional details on each of these categories below). Given the international readership of JBI, country-specific health systems or approaches will be considered only if they offer generalizable lessons that are relevant to the broader readership, regardless of their country, language, culture, or health system.Specific considerations for manuscripts in certain topical areas have also been provided in recent editorials.If you are considering an article with a focus on translational bioinformatics , please read this editorial. Biologic discoveries based on the use of routine informatics techniques may be important biologic contributions, but are not suitable for JBI. In addition, please note that JBI publishes bioinformatics papers only if they deal with issues in translational (human) science (e.g., translational bioinformatics papers).If you are considering an article describing a new machine learning approach, please read this editorial. Machine learning papers would be considered only if the methods that are introduced demonstrate substantial novelty and advancement beyond the current SoA and their evaluation is sound and includes an assessment of the potential of the method to be used in clinical practice. For example, submissions reporting publishing marginally SoA findings without an in-depth analysis or discussion of how the methods are potentially generalizable (or applicable in a wider setting) would not be considered. Novel and important clinical problems addressed by existing machine learning methods may warrant Special Communication papers if their discussion includes novel insights or lessons learned for future research in such domains.Authors considering an article on biomedical privacy and security, please read this editorial. To be considered, the privacy and security methods that are introduced should demonstrate substantial novelty and advancement beyond the SoA, should be specific to the biomedical informatics domain, and their practical application and/or likely real-world usefulness in the biomedical domain.Please note that papers related to signal processing, imaging, medical devices, or communication networks are outside the scope of the journal unless they combine knowledge-intensive approaches involving ontologies.Please also consult the editorial that explains where to direct Artificial Intelligence in Medicine-related manuscripts for peer review and possible publication, considering the different scope of the three Elsevier medical informatics journals: JBI, Artificial Intelligence in Medicine, and Intelligence-based Medicine.
  • Genetics in Medicine

    • ISSN: 1098-3600
    Genetics in Medicine (GIM) is an official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal is an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.In addition:GIM does not publish case reportsManuscripts reporting population level research carried out in predominantly or exclusively White populations will generally not be accepted without strong justification for lack of diversity in the population studied.The significance of articles reporting data and/or observations from a limited geographic region is evaluated in the context of whether they are generalizable across relevant populations or whether they might fill a knowledge gap in populations that are underrepresented in genetics research or that experience health disparities.Although cancer genetics is a focus, GIM discourages cancer genetics manuscripts with data limited to somatic and/or tumor genetics. Manuscripts with novel findings on non-germline genetics (for example, somatic [tumor] variation, CHIP [clonal hematopoiesis of indeterminate potential], somatic and constitutional mosaicism) that inform our understanding of germline risk may also be considered. Manuscripts reporting on circulating tumor DNA (ctDNA) or "liquid biopsy" are also generally not within the scope of GIM.Manuscripts should not contain previously published material without appropriate permission.GWAS studies are generally low priority for GIM.
  • Biologicals

    • ISSN: 1045-1056
    Biologicals is the official journal of the International Alliance for Biological Standardization. It provides a modern and multidisciplinary international forum for the publication of research that advances the development, manufacturing, quality control, standardization, safety, efficacy, and regulatory aspects of human and veterinary biological products derived from both novel and established biotechnologies. Research Areas include areas relevant to biologicals for human and veterinary use such as:Bacterial vaccinesBlood productsCell biologyCell culture technologyCellular immunology Cytokines and allied mediators Diagnostics Downstream processing Gene transfer and expression General bacteriology General virology, endogenous and adventitious viruses Hormones Immunochemistry Molecular biology Monoclonal antibodies Parasitology Prion and prion disease Protein chemistry Toxins ToxoidsViral vaccines
  • Thrombosis Research

    • ISSN: 0049-3848
    Vascular Obstruction, Hemorrhage and Hemostasis Affiliated journal to the North American Thrombosis Forum (NATF) and the Hemostasis and Thrombosis Research Society (HTRS)Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.
  • Ultramicroscopy

    • ISSN: 0304-3991
    An international journal affiliated with MSA, ISEM, SCANDEM, NVEM, SGOEM, SIME-SM, DGE, MSC, ASEM and MSSA, committed to the advancement of new methods, tools and theories in microscopyUltramicro... is an established journal that provides a forum for the publication of original research papers, invited reviews and rapid communications. The scope of Ultramicroscopy is to describe advances in instrumentation, methods and theory related to all modes of microscopical imaging, diffraction and spectroscopy in the life and physical sciences.Electron MicroscopyInstrument... developmentImaging and scattering theoryComputational methodsImage processing and analysisAuthors are encouraged to contact the Editor in Chief directly at angus.kirkland@mater... to discuss Review proposals in the first instance possible, as these are by invitation only.
  • Clinica Chimica Acta

    • ISSN: 0009-8981
    International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.